An official from the WHO confessed this Saturday that people who got the Monkeypox vaccine are part of the clinical study for data gathering, and the researchers can learn more about the shot’s effectiveness.
This Saturday, the WHO conducted a media briefing with WHO Director-General Tedros Adhanom Ghebreyesus and experts to talk about the Monkeypox outbreak.
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
“I would like to underline one thing that is very important to WHO. We do have uncertainty around the effectiveness of these vaccines because they haven’t been used in this context and in this scale before,” Tim Nguyen, the Unit Head of Global Infectious Hazards Preparedness at the World Health Organization Emergency Programme.
“And therefore, when these vaccines are being delivered, that they are delivered in the context of clinical trial studies and prospectively collecting this data to increase our understanding of the effectiveness of these vaccines,” he said.
The CDC stated that only two vaccines got a license by the US FDA against monkeypox. The WHO declared the monkeypox outbreak a global health emergency on Saturday, right before the elections.
Tedros overruled the decision of 8 members of the expert committee who didn’t support the declaration; only six were in favor.
Two sources stated that an expert committee was split on the decision, but the responsibility for the final decision was on the director-general Tedros.
“The NY Health Department announced plans for its next allocation of the JYNNEOS vaccine.” NYC Health Department said in a statement. “Approximately 26,000 additional doses were delivered to New York City as part of Phase 2b from the federal government and state and will be distributed via clinics, mass vaccination sites, and community-based referrals. Individuals will be able to book appointments for July 24 through August 13.”
“The Health Department is moving quickly to distribute as many vaccine doses as we can in the most equitable way possible,” said Health Commissioner Dr. Ashwin Vasan. “With cases rising, it’s clear that there is a great need for more vaccines in New York City, and we are working with our federal partners to obtain more doses.”